Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karla Medina

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|June 22, 2026
A Multilabel Single Molecule Localization Microscopy Protocol for Investigation of Chromatin in the Dense Nuclear EnvironmentNicolas Acosta, Ruyi Gong, Yuanzhe Su, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Three-color single-molecule localization microscopy in chromatinNicolas Acosta, Ruyi Gong, Yuanzhe Su, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Biomarker landscape in advanced NSCLC: insights from a national prospective registryMariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell disseminationPietro Berico, Cody Dunton, Luay Almassalha, et al.
Chest|July 17, 2025
KRAS Mutation Status in Non-Small Cell Lung Cancer: Distribution Across Occupational CategoriesRoberto Serna-Blasco, Karla Medina, María Ángeles Sala, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2025
Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS studyRoberto Serna-Blasco, Pilar Mediavilla-Medel, Karla Medina, et al.
The Lancet Regional Health. Europe|February 2, 2026
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in SpainMariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, et al.
Expert Opinion on Biological Therapy|May 20, 2026
Arian protocol: a phase iii study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancerMariano Provencio, David Aguiar, Mónica Antoñanzas, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|June 22, 2026
A Multilabel Single Molecule Localization Microscopy Protocol for Investigation of Chromatin in the Dense Nuclear EnvironmentNicolas Acosta, Ruyi Gong, Yuanzhe Su, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
Three-color single-molecule localization microscopy in chromatinNicolas Acosta, Ruyi Gong, Yuanzhe Su, et al.
Lung Cancer (Amsterdam, Netherlands)|August 1, 2025
Biomarker landscape in advanced NSCLC: insights from a national prospective registryMariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Chromatin architecture and physical constriction cooperate in phenotype switching and cancer cell disseminationPietro Berico, Cody Dunton, Luay Almassalha, et al.
Chest|July 17, 2025
KRAS Mutation Status in Non-Small Cell Lung Cancer: Distribution Across Occupational CategoriesRoberto Serna-Blasco, Karla Medina, María Ángeles Sala, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2025
Comprehensive molecular profiling of advanced NSCLC using NGS: Prevalence of druggable mutations and clinical trial opportunities in the ATLAS studyRoberto Serna-Blasco, Pilar Mediavilla-Medel, Karla Medina, et al.
The Lancet Regional Health. Europe|February 2, 2026
Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in SpainMariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, et al.
Expert Opinion on Biological Therapy|May 20, 2026
Arian protocol: a phase iii study of sacituzumab and zimberelimab for the treatment of patients with non-small cell lung cancerMariano Provencio, David Aguiar, Mónica Antoñanzas, et al.
Pageof 1